Effects of Escitalopram on Markers of Bone Turnover: A Randomized Clinical Trial

CONTEXT: Recent observational studies have suggested that the use of selective serotonin reuptake inhibitors is associated with an increased fracture risk and an accelerated bone loss, although conflicting results have been reported. Furthermore, because many of these studies have been performed in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Diem, Susan J., Joffe, Hadine, Larson, Joseph C., Tsai, Joy N., Guthrie, Katherine A., LaCroix, Andrea Z., Ensrud, Kristine E., Freeman, Ellen W., Leder, Benjamin Z.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Endocrine Society 2014
Konular:
JCEM Online: Brief Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4154080/
https://ncbi.nlm.nih.gov/pubmed/25014001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2288
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller